Back to top



Founded in Evidence


Scientific study database

Swiss DolorClast® devices are the most researched devices in clinical trials published on shock wave therapy in the PEDro database. Find these and other studies in our comprehensive library below to learn the evidence behind Guided DolorClast Therapy and how it can boost your practice's success.


Body Part

Dose-related effects of radial extracorporeal shock wave therapy for knee osteoarthritis: a randomized controlled trial

Ya-Fei ZHANG, MD, Yang LIU, MD, Shao-Wen CHOU, MD and Hao WENG, PhD
From the Department of Rehabilitation Medicine, Aerospace Center Hospital, Beijing, China

This study highlights the dose-related effect of the KOA ESWT treatment, and emphasizes the importance of selecting devices that offer the highest energy density for the purpose of achieving the greatest clinical outcome! 

Improving extracorporeal shock wave therapy with 904 or 905 nm pulsed, high power laser pre-treatment

Prof. Dr. med. Christoph Schmitz
Extracorporeal Shock Wave Research Unit, Chair of Neuroanatomy, Institute of Anatomy, Faculty of Medicine, LMU Munich, Munich, Germany

Extracorporeal shock wave therapy (ESWT) is a well-investigated and commonly used treatment modality in remedying a variety of musculoskeletal disorders. Combining High Power 905nm laser treatment and ESWT may increase the beneficial use of ESWT in physical and rehabilitation medicine.

Radial extracorporeal shock wave therapy is safe and effective in the treatment of chronic recalcitrant plantar fasciitis: results of a confirmatory randomized placebo-controlled multicenter study.

Gerdesmeyer L, Frey C, Vester J, et al.
Am J Sports Med 2008;36:2100- 2109

Chronic plantar fasciopathy can be treated efficiently with radial shock wave therapy, which can be administered to outpatients without having to reccur to anesthesia. This randomized controlled trial aims at demonstrating therapeutic superiority vs. placebo.